Metraipolis › archive › dc_309501965117
Comparative Efficacy and Safety of Tirzepatide Versus Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis — Europe PMC PMID:41975852
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41975852
- DOI
- 10.3390/healthcare14070850
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T19:36:10.115Z
- SHA-256 of the archived text
a0057fac494884fb08b9a9fd676d817d0dbbb69f88d56ffd261cea25b249a6ea- Stable URL of this page
https://metraipolis.com/documento/dc_309501965117
How to cite
Comparative Efficacy and Safety of Tirzepatide Versus Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis — Europe PMC PMID:41975852 — Europe PMC (en), https://europepmc.org/article/MED/41975852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_309501965117 (Metraipolis archive dc_309501965117, sha256 a0057fac494884fb08b9a9fd676d817d0dbbb69f88d56ffd261cea25b249a6ea)
BibTeX
@misc{dc309501965117,
title = {Comparative Efficacy and Safety of Tirzepatide Versus Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis — Europe PMC PMID:41975852},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41975852},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_309501965117; sha256 a0057fac494884fb08b9a9fd676d817d0dbbb69f88d56ffd261cea25b249a6ea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41975852. Agents can read the archived copy with the MCP tool read_document.